A detailed history of Fermata Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fermata Advisors, LLC holds 3,847 shares of NVO stock, worth $326,995. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,847
Previous 3,695 4.11%
Holding current value
$326,995
Previous $527,000 13.09%
% of portfolio
0.09%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$119.07 - $145.42 $18,098 - $22,103
152 Added 4.11%
3,847 $458,000
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $167,008 - $199,944
1,361 Added 58.31%
3,695 $527,000
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $238,324 - $317,237
2,334 New
2,334 $299,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fermata Advisors, LLC Portfolio

Follow Fermata Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fermata Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fermata Advisors, LLC with notifications on news.